13:20:21 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-27 Bokslutskommuniké 2024
2024-11-28 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-05-16 Kvartalsrapport 2024-Q1
2024-05-13 Ordinarie utdelning DEAR 0.00 SEK
2024-05-08 Årsstämma 2024
2024-02-22 Bokslutskommuniké 2023
2024-01-31 Extra Bolagsstämma 2024
2023-11-30 Kvartalsrapport 2023-Q3
2023-08-24 Kvartalsrapport 2023-Q2
2023-05-04 Kvartalsrapport 2023-Q1
2023-04-13 Ordinarie utdelning DEAR 0.00 SEK
2023-04-12 Årsstämma 2023
2023-02-23 Bokslutskommuniké 2022
2022-11-17 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-19 Kvartalsrapport 2022-Q1
2022-04-08 Ordinarie utdelning DEAR 0.00 SEK
2022-04-07 Årsstämma 2022

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Duearity är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling och produktion av tekniska lösningar för behandling och lindring av tinnitus. Produktportföljen inkluderar exempelvis bolagets egenutvecklade produkter Tinearity och Duearity. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten bedrivs inom Sverige.
2024-02-06 08:53:00

Duearity Americas Inc has entered into a partnership with a national distributor in the USA that has a unique digital trading platform for products in the field of hearing health. The distributor has evaluated Tinearity G1 and is now offering Tinearity G1 to clinics throughout the United States.

The distribution company Oaktree Products has evaluated Tinearity G1 and has decided that the product should be included in the company's trading platform, which means that the product can be sold and distributed to clinics throughout the United States. The advantage for Duearity is, firstly, that the distributor is licensed in all states. Secondly, the distributor has high trust among clinics, which puts a stamp of quality on Duearity as a company and Tinearity G1 as a product. Thirdly, the collaboration means that clinics can easily order Tinearity G1 on Oaktree's trading platform. As a consequence, this means a simplified distribution chain where the product is sent directly to clinics via Oaktree. Oaktree Products only sells products in the field of ear and hearing health and only to professionals and clinics.

Duearity Americas Inc are involved in negotiations with more distributors in the US. The goal is to enter into a second distributor agreement during the first quarter of 2024 with a company that has a well-developed sales organization in the US and that covers important sales channels in the country.